"This is the Titanic." That's how former Medtronic Chairman and CEO Bill George described Obamacare. He predicted the troubled federal website won't be fixed by the end of the month.» Read More
Some of the names on the move ahead of the open.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Check out companies that are making moving after the bell Thursday:
From auto sales to health care to the NFL to the price of gasoline, CNBC's anchors, reporters, editors and contributors make calls on what 2013 will bring.
How everyone will deal with the effects of Obamacare in 2013.
Oct 25- Medical device maker Medtronic Inc edited health journal articles and paid doctors millions of dollars for company-sponsored studies of its Infuse bone-grafting product used in spinal surgery, according to a U.S. Senate report published on Thursday.
WASHINGTON-- Medical device maker Medtronic Inc. helped write and edit medical journal articles attributed to outside physicians, which downplayed the risks of the company's best-selling bone graft, according to a report by Senate investigators.
Medical device maker Medtronic Inc. helped write and edit medical journal articles attributed to outside physicians, which downplayed the risks of the company's best-selling bone graft, according to Senate investigators.
CNBC's Herb Greenberg raises a red flag on Medtronic.
NEW YORK-- Shares of orthopedic implant makers mostly traded higher Thursday, but analysts said industry bellwether Biomet's earnings are cause for concern.
*Medtronic, Stryker are main manufacturers By Frederik Joelving. What's more, the orthopedic products add more than $4,000 in hospital charges for the surgery, according to a new study published on Tuesday in Journal of the American Medical Association. Emily Dodwell, a surgeon at the Hospital for Special Surgery in New York, who led the research.
Take a look at some of Friday's midday movers:
*Debt financing soars among larger medical device makers By Susan Kelly. CHICAGO, Oct 1- Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures for healthcare, a report by Ernst& Young said.
Omar Ishrak, Medtronic chairman & CEO, discusses earnings and the future direction of the company. "Our new products," he says, "are beginning to have an impact."
China seems destined to become the world’s biggest pharmaceutical market; however, whether the profits multinational corporations realize will be similarly attractive remains very much in doubt.
One says it's time to move on, one expects drastic changes. These were some of the opinions from health-care insiders after the Supreme Court upheld President Obama’s health care overhaul.
Take a look at some of Thursday's midday movers:
Trader Steve Grasso thinks the sell-off in one stock presents an opportunity. “The tax is already in the 2013 numbers,” he says.
Take a look at some of Friday’s morning movers:
Take a look at some of Tuesday's midday movers: